Loading company details...
Beta
Latest Form 4 (Oct 17, 2025): Catherine Do (Director): Other (see footnotes) of 100,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2025 | Catherine Do | Other (see footnotes) | 100,000 | n/a |
| Oct 2, 2025 | Myron W. Shulgan | Other (see footnotes) | 100,000 | n/a |
| Oct 1, 2025 | Glenn C. Worman, CFO | Other (see footnotes) | 100,000 | n/a |
| Oct 1, 2025 | Lynn Stockwell, CEO and Exe. Chair of Board | Purchase | 700,000 | n/a |
| Oct 1, 2025 | Drugs Made In America Acquisition II LLC | Purchase | 700,000 | n/a |
| Oct 1, 2025 | Sridhar G. Prasad | Other (see footnotes) | 100,000 | n/a |